Phase 2 Cognition Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
Evaluation of the Effect of L-Arginine on the Cognitive Function in Geriatric Patients
Cognition Disorders in Old AgeCognitive and Behavioral Impairment
German University in Cairo60 enrolled1 locationNCT07338682
Recruiting
Phase 2
Impact of NANO-PSO on Cognition in Older Adults with Mild to Moderate Cognitive Impairment
Cognition
Distribuidora Biolife SA de CV60 enrolled1 locationNCT06520878
Recruiting
Phase 2Phase 3
Oxytocin's role in social cognitive changes in ageing
Cognition
Australian Catholic University120 enrolled1 locationACTRN12618001343291
Recruiting
Phase 2
The effect of Memantine on cognition disorders induced by Electroconvulsive therapy (ECT)
Post ECT cognition disorders
Mohammad Abbasinazari40 enrolled1 locationACTRN12614000619640
Completed
Phase 2
The effect of transdermal testosterone gel300mcg daily on cognitive performance in older postmenopausal women: a placebo controlled trial over 26 weeks
cognition in older postmenopausal women
Monash University120 enrolled1 locationACTRN12609000981224